Techno Trends

TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.

NRX-101 Represents New Class of Antidepressants to Decrease Suicidal Thoughts

NeuroRx39s NRX101 the first oral drug targeting suicidal bipolar depression helps to treat severe bipolar depression with Acute Suicidal Ideation Behavior ASIB NRX101 is used for treatment of Severe Bipolar Depression with Acute Suicidal Ideation Behaviour after initial stabilisation with ketam..

Researchers Design and Develop New Class of Molecules to Halt Tumors

Researchers at Stevens Institute of Technology and colleagues have designed and developed a new class of molecules that use a neverbeforeknown mechanism that may halt or destroy breast cancer tumors This mechanism can be used for patients with drugresistant or dangerously metastatic stages of the..

Insmed Announces ARIKAYCE® For the Treatment of Mycobacterium Avium Complex (MAC) Lung Disease

Insmed Inc announced ARIKAYCE amikacin liposome inhalation suspension for the treatment of Mycobacterium Avium Complex MAC lung disease as part of a combination antibacterial drug regimen for adult patients ARIKAYCE can be used for patients with MAC lung disease a chronic and debilitating conditi..

NUS and Harvard Scientists Develop Novel Drug to Treat Liver Cancer Effectively

A team of Scientists from the Cancer Science Institute of Singapore CSI Singapore at the National University of Singapore NUS developed a novel peptide drug called FFW to treat liver cancer effectively FFW could potentially stop the development of Hepatocellular Carcinoma HCC or primary liver can..

Pfizer Launches Janus Kinase 3 (JAK3) Inhibitor PF-06651600

Pfizer launched its investigational oral Janus Kinase 3 JAK3 inhibitor PF06651600 which is used for the treatment of patients with alopecia areata Alopecia areata is chronic autoimmune skin disease in which immune cells attack healthy hair follicles causing hair loss in round patches and causes h..

Alnylam’s ONPATTRO to Treat Patients with Hereditary ATTR Amyloidosis in Adults

Alnylams ONPATTRO patisiran lipid complex injection is a firstofitskind RNA interference RNAi therapeutic used to treat the polyneuropathy of hereditary transthyretinmediated hATTR Amyloidosis in adults RNAi is a completely new approach to the treatment of these diseases targeting the faulty prot..

Encorafenib (BRAFTOVI™) to Treat Patients with BRAFV600E-Mutant Metastatic Colorectal Cancer (mCRC)

Encorafenib BRAFTOVI in combination with binimetinib MEKTOVI and cetuximab has been designed to treat patients with BRAFV600Emutant metastatic colorectal cancer mCRC BRAFV600Emutant mCRC will be an important treatment option to the cancer patients in critical need The results were made from th..

Daiichi Sankyo’s FLT3 Inhibitor Quizartinib Treats Relapsed/Refractory FLT3-ITD AML

Daiichi Sankyo Company Limited announced quizartinib an investigational FLT3 inhibitor for the treatment of adult patients with relapsedrefractory FLT3ITD Acute Myeloid Leukemia AML Quizartinib is the first FLT3 inhibitor to enhance overall survival as an oral single agent compared to chemotherap..

Portola Pharmaceuticals Introduces Antidote for the Reversal of Factor Xa Inhibitors

Portola Pharmaceuticals develops Andexxa coagulation factor Xa recombinant inactivatedzhzo the first and only antidote indicated for patients treated with rivaroxaban and apixaban when reversal of anticoagulation is needed due to lifethreatening or uncontrolled bleeding Andexxas rapid reversal of..

Amgen and Novartis Pharma Collaborate to Develop Novel Approach for Migraine Prevention

Amgen in collaboration with Novartis Pharma AG has developed Aimovig a novel therapeutic approach to prevent a migraine by blocking the calcitonin generelated peptide receptor CGRPR which is believed to play a critical role in a migraine Aimovig 70 mg is selfadministered once monthly via Amgen39s..